Article
EGFR gene alterations as a prognostic biomarker in advanced esophageal squamous cell carcinoma.
Frontiers in bioscience (Landmark edition) - 1 Jan 2010
Kaneko Kazuhiro, Kumekawa Yosuke, Makino Reiko, Nozawa Hisako, Hirayama Yuichi, Kogo Mari, Konishi Kazuo, Katagiri Atsushi, Kubota Yutaro, Muramoto Takashi, Kushima Miki, Ohmori Tohru, Oyama Tsunehiro, Kagawa Norio, Ohtsu Atsushi, Imawari Michio
Abstract excerpt
Esophageal squamous cell carcinoma (ESCC) exhibits abnormalities in epidermal growth factor receptor (EGFR) gene. To identify a prognostic marker, the overexpression of EGFR protein, mutations in EGFR and p53 mutations were analyzed in pretreatment biopsy specimens removed from T3-4 and/or M1 LYM ESCC patients who received chemoradiotherapy. A silent mutation comprised of a single nucleotide polymorphism (SNP) at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
